Apolipoprotein E polymorphism and hyperlipidemia.
The DOI matches its Crossref record.
Abstract
We tested apolipoprotein E phenotypes in 1557 normolipidemic factory workers and 822 hyperlipidemic hospital patients. We distinguished six different apolipoprotein E phenotypes and determined their frequencies in normolipidemia (factory workers), hypertriglyceridemia, hypercholesterolemia, and mixed hyperlipidemia. For the three homozygous phenotypes E3/3, E4/4, and E2/2, the percentage distribution in the normolipidemic group was 62.2%, 2.2%, and 0.9%, respectively; for the three heterozygous phenotypes E4/3, E3/2, and E4/2, we determined frequencies of 19.9%, 11.7%, and 2.9%, respectively. A higher prevalence of E2/2 homozygosity was observed in hypertriglyceridemic persons (2.5%) and persons affected by mixed hyperlipidemia (5.0%). E4/4 homozygosity occurred more often among hypercholesterolemic patients (5.0%) than normolipidemic persons (2.2%). These data suggest that E2/2 homozygosity and E4/4 homozygosity both predispose to hyperlipidemia. Patients affected by mixed hyperlipidemia should be investigated for their apolipoprotein E polymorphism because of the possible linkage of apolipoprotein E2/2 homozygosity, hyperlipidemia, and atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review
Eichner, J. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.6.487 · Cited by 796
“Caucasians Framingham, Massachusetts (12) Munster, West Germany (13) Finland (14)”
BackgroundInfluentialApolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study
Wilson, P. W. F. (1994) · JAMA · doi:10.1001/jama.1994.03520210050031 · Cited by 468
Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113243 · Cited by 418
Ehnholm, C., Lukka, M., Kuusi, T., Nikkilä, E., & Utermann, G. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38833-7 · Cited by 405
Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype.
Kesäniemi, Y. A., Ehnholm, C., & Miettinen, T. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113107 · Cited by 402
APOE distribution in world populations with new data from India and the UK
Singh, P. P., Singh, M., & Mastana, S. S. (2006) · Annals of Human Biology · doi:10.1080/03014460600594513 · Cited by 351
Apolipoprotein E: an important gene and protein to follow in laboratory medicine
Siest, G., Pillot, T., Régis-Bailly, A., Leininger-Muller, B., Steinmetz, J., Galteau, M. M., & Visvikis, S. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.8.1068 · Cited by 347
Abnormal in vivo metabolism of apolipoprotein E4 in humans.
Gregg, R. E., Zech, L. A., Schaefer, E. J., Stark, D., Wilson, D., & Brewer, H. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112645 · Cited by 345
“Type III hyperlipoproteinemia is associated with homozygosity for the E2 allele (2, 3) while the E4 allele is associated with type V hyperlipoproteinemia (4) and increased plasma cholesterol levels (5-7).”
BackgroundInfluentialGerdes, L. U., Klausen, I. C., Sihm, I., Faergeman, O., & Vogler, G. P. (1992) · Genetic Epidemiology · doi:10.1002/gepi.1370090302 · Cited by 318
Familial apolipoprotein E deficiency.
Schaefer, E. J., Gregg, R. E., Ghiselli, G., Forte, T. M., Ordovas, J. M., Zech, L. A., & Brewer, H. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112704 · Cited by 313
Weisgraber, K. H. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42621-5 · Cited by 304
Ordovas, J. M., Litwack-Klein, L., Wilson, P. W., Schaefer, M. M., & Schaefer, E. J. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38690-9 · Cited by 238
Eto, M., Watanabe, K., & Ishii, K. (1986) · Clinical Genetics · doi:10.1111/j.1399-0004.1986.tb00547.x · Cited by 112
Weisgraber, K. H., & Shinto, L. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99060-5 · Cited by 104
Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins
Steinmetz, A., Jakobs, C., Motzny, S., & Kaffarnik, H. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.3.405 · Cited by 93
Genetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes
Zannis, V. I., Kardassis, D., & Zanni, E. E. (1993) · Advances in Human Genetics 21 · doi:10.1007/978-1-4615-3010-7_3 · Cited by 78
Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility
Hegele, R. A., Breslow, J. L., & Cloninger, C. R. (1987) · Genetic Epidemiology · doi:10.1002/gepi.1370040302 · Cited by 60
Zhang, X., Tian, Q., Liu, D., Geng, T., Xu, X., Ge, S., Zheng, D., Wu, L., Song, M., Hou, H., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0822-x · Cited by 51
Implications of apolipoprotein E genotype on inflammation and vitamin E status
Huebbe, P., Lodge, J. K., & Rimbach, G. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900398 · Cited by 43
Sparks, D. L., Liu, H., Gross, D. R., & Scheff, S. W. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11357-6 · Cited by 39
Metadata
- Authors
- Assmann, G., Schmitz, G., Menzel, H. J., & Schulte, H.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 1984-05-01
- Volume
- 30
- Issue
- 5
- Pages
- 641-643
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2259265492
- Cited by
- 135
- References
- 0
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.